New Analysis Method Melts DNA to Detect Pathogens Faster
This method is faster than blood cultures and is less likely to generate false positives compared to other DNA detection-based technologies.
Read MorePosted by Andy Lundin | Feb 21, 2024 | Sepsis |
This method is faster than blood cultures and is less likely to generate false positives compared to other DNA detection-based technologies.
Read MorePosted by Chris Wolski | Feb 1, 2024 | Emerging & Zoonotic Diseases |
Picodya has developed a scalable solution that is being used by the NIH to find Disease X and stop the next pandemic in its tracks.
Read MorePosted by Andy Lundin | Jan 11, 2024 | Infectious Diseases |
Wastewater surveillance is a potent tool in understanding COVID transmission within school settings, according to a new study.
Read MorePosted by Andy Lundin | Jan 9, 2024 | Diagnostic Technologies |
Picodya, the creator of a hybrid IVD solution for multiplexed POC testing, announced the deployment of its B-Matrix technology in NIH labs.
Read MorePosted by Andy Lundin | Jan 2, 2024 | Covid 19 |
An artificial intelligence (AI) model can predict which COVID variants are likely to cause new waves of infection.
Read More